Neurocrine Biosciences, Inc. ( NBIX) Discusses Progress and Strategy in Neurology and Obesity R&D Programs December 16, 2025 12:00 PM EST ...
Cliff Fischer, Sharon Morrison, and Mohr Partners' Robert Shibuya reveal how the deal came together—and what it means for the industry. Making Dallas an Even Better Place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback